首页> 外文期刊>Journal of public health management and practice: JPHMP >Using the North Dakota IIS to Assess the Response of Health Care Providers to the ACIP Recommendation for Tdap Vaccination During Pregnancy
【24h】

Using the North Dakota IIS to Assess the Response of Health Care Providers to the ACIP Recommendation for Tdap Vaccination During Pregnancy

机译:利用北达科他州IIS评估医疗提供者对怀孕期间TDAP疫苗接种的ACIP推荐的响应

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: To evaluate the response of North Dakota health care providers to follow the recommendation set forth by the Advisory Committee on Immunization Practices (ACIP) to administer a dose of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine to women during each pregnancy using the North Dakota Immunization Information System (NDIIS). Methods: Data from the NDIIS for North Dakota infants born during calendar years 2013-2018 were extracted. Mother's name was taken from the newborn records and matched to NDIIS female client records to identify the population of mothers of newborns who would have been recommended to receive Tdap during their pregnancy. Doses of Tdap vaccine administered after October 1, 2012, were extracted from the NDIIS, and the dose records were matched back to the mother's record. The time from baby's birthdate back to the doses of Tdap vaccine administered to the mother was measured to find any doses that would have been administered during pregnancy. Results: The percentage of women receiving Tdap vaccine during pregnancy increased from 31.5% in 2013 to 60.6% in 2018. Of those women who received Tdap during pregnancy, 94% received the vaccine during the ACIP-recommended interval of 27 to 36 weeks' gestation, using the assumption that all babies were born at 40 weeks' gestation. Conclusions: North Dakota health care providers have responded positively to the recommendation of the ACIP to administer a dose of Tdap vaccine to women during each pregnancy and have increased their administration of the vaccine to their patients.
机译:目标:评估北达科他州卫生保健提供者遵循免疫惯例(ACIP)咨询委员会提出的建议,以在每次怀孕期间给妇女施用一剂破伤风,白喉和无细胞植物(TDAP)疫苗北达科他州免疫信息系统(NDIIS)。方法:提取2013 - 2018年日历年间出生于北达科他州婴幼儿的NDIIS的数据。母亲的名字是从新生儿记录中取出,并与NDIIS女性客户记录相匹配,以确定在怀孕期间建议接受TDAP的新生儿母亲人口。在2012年10月1日之后施用的剂量TDAP疫苗从NDIIS中提取,剂量记录与母亲的记录相匹配。测量从婴儿出生的时间返回给母亲给予母亲的TDAP疫苗的时间,以找到在怀孕期间施用的任何剂量。结果:2013年接受TDAP疫苗接受TDAP疫苗的百分比增加到2013年的31.5%至2018年的60.6%。在怀孕期间接受TDAP的妇女,94%在占地27至36周的妊娠期间隔内接受疫苗,使用所有婴儿出生在40周的妊娠的假设。结论:北达科他州医疗保健提供者对母鸡的建议进行了肯定的作用,以在每次怀孕期间向女性施用一剂TDAP疫苗,并增加他们对患者的疫苗给予疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号